chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a healthcare worker, refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 13-APR-2016, the patient was vaccinated with 0.5 ml dose of improperly stored (Merck) VARIVAX (which had a lot # of L040419 and an expiration date of 14-OCT-2017; however, dosage number and route of administration were not reported). Nonetheless, no adverse effects were reported. Another batch of (Merck) VARIVAX (which had a lot # of L043624 and an expiration date of 03-NOV-2017) had also been improperly stored but it was not reported whether it had been administered. The vaccines experienced the following temperature excursions on the following dates: 10 F for 2 hours and 15 minutes on 24-MAR-2016; 12.4 F for 2 hours and 15 minutes on 26-MAR-2016; 10.4 F for 2 hours and 15 minutes on 30-MAR-2016; 10 F for 2 hours on 03-APR-2016; and 9.3 F for 1 hour and 45 minutes on 07-APR-2016. Reportedly, there had been no previous temperature excursions and the aforementioned ones were identified due to a data logger. Furthermore, no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
The pt developed a fever of 101; 24 hours post vax. The pt broke out in a rash 10 days post vax. The rash was raised and itchy.
Resting heart rate (HR) was at 64, resting blood pressure (BP) prior to vaccine was at 107/68 (Which is historically normal for me) About 30 minutes after vaccination the lights in the room started to appear as streaks. My HR shot up to 99 and BP was at 135/83. (My heart felt like it was going to burst out of my chest.) This level of elevated cardiovascular output was endured for about 3 hours.   Treatment included meditation and conscious, focused intent to slow HR down and reduce BP.  Lymph nodes were rock hard and it became difficult to talk or swallow. This seemed more of a normal vaccine response, it only lasted for about an hour, after I took my immune boosting supplements.
Extensive chills, injection site extremely sore. Complete body weakness, Muscles sore from tips of fingers thru end of toes. (Legs, arms etc). Nausea, light headed and feeling faint. Couldn't get up off chair or couch with help.
redness, pain, swelling, a hard oval lump 3in x 2in and  bruising at the injection site, headache, fatigue
i had shingles after having had the shot mild but still/Suspect vaccination failure; i had shingles after having had the shot mild but still; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but captured as an adult as per vaccine indication The patient received Shingrix and experienced mild case of shingles. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown.
Allergic reaction of redness and itching to the upper arm, around injection site that occurred about 6 days after the shot. Recommended use of BENADRYL to patient today.
SHORTLY AFTER ADMINISTRATION, PATIENT STARTED TO PERSPIRATE AND PALE. HIS BLOOD PRESSURE AND TEMPERATURE WERE TAKEN AT 4:36 PM BP WAS 178/75, TEMPERATURE WAS 97.8 DEGREES F AND TAKEN AGAIN AT 4:50, BP 123/75, TEMPERATURE WAS 97.0.
Information has been received from a physician referring to an unspecified number of patients of unknown age and gender. Information about patients' concurrent conditions and medical history was not reported. The physician reported that the patients were vaccinated with doses of improperly stored VAQTA (dose and route not reported, lot number reported as L023936 with expiration date 15-MAR-2017) on unspecified dates starting on or after 14-SEP-2015. No adverse effect was reported. This is one of several reports received from the same reporter (other linked case # 1510USA010113). Additional information has been requested.
Strong metallic taste in mouth 5 minutes after dose; Strong headache about 20 minutes after dose; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 25Mar2021, at 15:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, obesity and high blood pressure. The patient had no allergies to medications, food or other products. Concomitant medications included montelukast sodium (SINGULAIR), sertraline hydrochloride (ZOLOFT) and irbesartan (MANUFACTURER UNKNOWN) all for unknown indicatio, from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Mar2021 at 15:15, the patient experienced strong metallic taste in mouth 5 minutes after dose and strong headache about 20 minutes after dose. No therapeutic measures were taken as a result of reported adverse events. The clinical outcome of the events strong metallic taste in mouth 5 minutes after dose and strong headache about 20 minutes after dose was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Patient took dose #1 on 6/1/22. On 6/2, started developing severe diarrhea, cramping, nausea, headache, and fever reaching 103 degF. The diarrhea improved and patient took dose #2 on 6/3/22, but continued to have a headache to this date. The fever lasted total 3 days.  Patient took tylenol for her symptoms, which helped. She did not have to seek medical attention.
The day following injection patient developed fever, chills, body aches, nausea, vomiting. Three days after the injection she noticed swelling, redness, warmth, pain of L upper arm.
Sister of pt stopped by clinic to pay for vax. Stated that flu shot caused sister's death. Began to feel ill next day. Transported to ER on 11/12 by ambulance, died few hrs later. Stated pt didn't see MD between 10/20 & 11/12/99.
headache; Body aches; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration, administered on the left arm on 11Feb2021 15:45 at a single dose for COVID-19 immunisation. Medical history included allergies: sulfa. The patient's concomitant medications were not reported. On Feb2021 the patient experienced headache and body aches. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The facility where the vaccine was administered was in a hospital. Patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering.   Information on the lot/batch number has been requested.
. Her injection site went crazy, it looked like a hockey puck, it was hot, hard, like it had a fever, it was swollen and red; . Her injection site went crazy, it looked like a hockey puck, it was hot, hard, like it had a fever, it was swollen and red; . Her injection site went crazy, it looked like a hockey puck, it was hot, hard, like it had a fever, it was swollen and red; . Her injection site went crazy, it looked like a hockey puck, it was hot, hard, like it had a fever, it was swollen and red; chills a little bit; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jan2021 11:00 (Batch/Lot Number: EL9264) as SINGLE DOSE for covid-19 immunisation. Patient's medical history included Smoker, Arthritis in her wrist and in November she had gotten an injection in the wrist for the arthritis, Allergy, environmental allergies, arthritis in neck and arthritis in back. Concomitant medication(s) included fluticasone propionate (FLONASE ALLERGY RELIEF) taken for hypersensitivity from an unspecified start date and ongoing; cetirizine hydrochloride (ZYRTEC ALLERGY) taken for hypersensitivity from an unspecified start date and ongoing. These medications are 365 days for allergies. No vaccines administered on the same date or within four weeks prior. On 29Jan2021 at 13:00, patient experienced Chills, a little bit. The event chills only lasted a couple hours, she wrapped up in a blanket, took a nap and she was fine. It was reported that on 07Feb2021, her injection site swelled up to a size of a hockey puck with redness, hardness. The patient stated that she had no problem with it until last Sunday on 07Feb2021. Her injection site went crazy, it looked like a hockey puck, it was hot, hard, like it had a fever, it was swollen and red. Upon follow-up, she woke up with it and she clarified that she did not have a fever, she felt fine it was just the injection site. Her 2nd dose was scheduled on 19Feb2021, next Friday and she wanted to know if she could take the 2nd shot as she had heard that people will experience worse side effects on the 2nd shot. She really wanted to be had taken the 2nd shot for that level of comfort. The patient underwent lab tests and procedures which included X-Ray: Unknown result on an unspecified date in November. On 07Feb2021 as the treatment for the event Injection site swollen and red, the patient received Benadryl and she put ice on it and has been 99% better, but she can still see a shadow of redness and there was a little heat, the swelling had gone. The outcome of the event Chills, vaccination site swelling was recovered, vaccination site warmth, vaccination site erythema was recovering and vaccination site induration was unknown.
I have uncomfortable tingling in both of lower legs and both feet. Somethings my feet feel too warm and I have to remove my shoes and socks for relief. This condition has been continuous since June 2021. I received my J&J one dose vaccination on 4-1-2021
Pt. reported breathing difficulties about 6 hr after immunization. Has pre-existing COPD and took some prednisone and used rescue inhalers with no real improvement. Was advised to go to urgent care or ER if symptoms did not improve in the next few hours.
pt recv vax 1MAY97 & in 1997 pt failed to seroconvert;
Swollen shoulder, pain in shoulder in line with the injection site.  Tiredness, fever for two nights.
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Woke up in the middle of the night and felt dizzy) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Woke up in the middle of the night and felt dizzy). On 14-Mar-2021, DIZZINESS (Woke up in the middle of the night and felt dizzy) had resolved.            Concomitant medications included unspecified high blood pressure medication.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not Applicable.    This case was linked to MOD-2021-058186 (Patient Link).
Pt recv vax on 2/25/99; 35 min post vax pt exp rash all over body
From the patient (a employee) "So, I think I am having a reaction to the vaccine.  I did call my PCP to check in and they also said to notify you.  I felt fine until last night about 8 PM.  Then I got body aches, headache, nausea, tachycardia, no fever.  During the night I had to use my nebulizer 3 times to keep sat > 86.    As I did some research through the night, some Covid patients were found to have positive Epstein Barr.  That is what I had in September (EBV) that put me down for 3 months.  So I am wondering if it caused a relapse of that.  Hope not.
Patient reports nerve pain (score 8 out of 10) in the right hand below wrist on the pinky side
Patient came back to the pharmacy about an hour after receiving the shot, complaining of hives and itching. Patient was given diphenhydramine 50mg capsule and after 15 minutes patient stated they felt better.
Soreness in left arm near injection site similar to what occurred immediately after the getting the injection.  This faded over the course of a couple of days.  Abnormal fatigue and feverishness similar to the flu for a few hours only.
Today after I got the flu vaccine, my nose started bleeding. I held my head back and the bleed calmed down and stopped.  No bleeding at this time.
Chest pain 2 days following vaccine. Was admitted to hospital and diagnosed with myocarditis. Please note that he had Coxsackie related myocarditis in May 2019.
Swollen arm.  Eight days after injection.  Itchy skin not just at injection site.  Possible swollen glands.
I26.92 SADDLE PULMONARY EMBOLISM 1/28/2023 PALATE LACERATION, INIT I26.99 ACUTE PULMONARY EMBOLISM 1/23/2023 PALATE LACERATION, INIT J96.00 ACUTE RESPIRATORY FAILURE 1/28/2023 PALATE LACERATION, INIT J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/23/2023 PALATE LACERATION, INIT R57.9 SHOCK, UNSPECIFIED 1/28/2023 PALATE LACERATION, INIT
Approx 2 hours after the booster. She became suddenly lightheaded. When she stood up she felt dizziness and started feeling off-balance. She attempted to walk 10 feet to lay down and her legs would not move forward. She attempted to use the wall to sit down. Halfway towards sitting, she felt everything go black.
Body aches; Chills; Dizzy; Felt like the flu was coming on; Felt very hot; Very blurry eyes; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: TW0150) via an unspecified route of administration in the left arm on 03Apr2021 at 14:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, depression and COVID-19. Concomitant medications included clonazepam (KLONOPIN) 10 milligram (mg) and testosterone (MANUFACTURER UNKNOWN) 200 mg. The patient did not have any known allergy to any medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021, immediately after vaccination, the patient experienced very blurry eyes. On the same day at 17:00, about 3 hours later, the patient experienced chills, dizzy and felt like the flu was coming on and all the night, the patient felt very hot with chills. Next day, on 04Apr2021, the patient had chills and body aches. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events very blurry eyes, chills, dizzy, felt like the flu, felt very hot and body aches. The clinical outcomes of the events very blurry eyes, chills, dizzy, felt like the flu, felt very hot and body aches were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
High heart rate; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (High heart rate) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced TACHYCARDIA (High heart rate). At the time of the report, TACHYCARDIA (High heart rate) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Heart rate increased: 100-140 (High) 100-140 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
I am not dure if it was Fluad or the lot number. pediatrics wo6ld have those details. Right eye rolled inward  15 min after  flu shot was administered.
Initial unsolicited report received from a consumer on 28 April 2015. A male patient age not reported, whose concomitant medications were not reported, had received a dose of Imovax rabies on 12 March 2015 and a dose of Imogam on 28 February 2015 (batch number, expiry date, dose number, route and site of administration were not reported for both the vaccines). Medical history included prostatectomy four years ago on an unspecified date, XBRT and had spent two years on hormone replacement therapy. Prostate specific antigen test on 31 March 2015 showed 0.015 and again on 2 April 2015 showed elevation from 0.015 to 0.018. Laboratory investigations included prostate specific antigen test on 31 March 2015 and again on 2 April 2015 showed elevation from 0.015 to 0.018. Corrective treatments were not reported. At the time of report, the outcome of event was unknown. Documents held by sender: None.
Janssen COVID-19 Vaccine EUA - chills, extremely tired, low grade fever started about 12 hours after injection (only at night)- reporting this 42hrs later - Advil helped with fever and sleep helped with tiredness
Patient was given a high dose flu vaccine today at appointment. Records updated in patient's chart after the vaccine was given and showed that patient received a flu vaccine in October 2022. Writer asked patient and he has no memory of getting a flu vaccine in 2022;
Muscle aches, high fever started roughly 1 day after the vaccination. Fever subsided after about 6 -7 hours.
Seizure.  Pharmacist told us it was normal and when she felt better, we could leave.
Burning mouth syndrome for 3 weeks; This is a spontaneous report from a contactable nurse, the patient. A 62-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6203) via an unspecified route of administration in the left arm on 26Feb2021 at 10:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The medical history included cardiac surgery, abd surgery, depression, anxiety and memory impairment. The patient had a history of allergy to Zyban and Levaquin drugs. The concomitant medications included nifedipine (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN), Vit B12, Fish Oil for an unknown indication. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Feb2021, the patient experienced burning mouth syndrome for 3 weeks. No therapeutic measures were taken for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the burning mouth syndrome was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Moderna vaccine was administered outside of facility - reported by patient ? NO LOT NUMBER WERE SUPPLIED ----------------------------------------------------------------------------------------------------------------------- I82.409 ACUTE DVT, UNSPECIFIED VEIN 4/8/2021 AT RISK FOR CARDIOVASCULAR DISEASE I82.409 ACUTE DVT, UNSPECIFIED VEIN 4/8/2021 ESRD (END STAGE RENAL DISEASE) I82.409 ACUTE DVT, UNSPECIFIED VEIN 4/8/2021 HYPERTENSIVE URGENCY
Patient has a history of a pseudotumor from 1998 (patient was 9 years old) that required a resection.  Since being "immunized" patient has now had a recurrence of the brain cyst that will require a craniotomy in order to perform a resection of the cyst.  Patient's vitals have been stable but he has not had surgery yet.  Surgery is planned for Tuesday 5/31/22
pt became limp w/fever to 103 2 days p/vax was administered; mom reports refused to eat or drink; took pt to MD; mom had not reported this reaction until 16SEP92 x/to MD;
Herpes Zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 75 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 09-APR-2009, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster and was treated by a physician. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
This spontaneous report received from a consumer concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included: had Covid-19 before vaccination, and other pre-existing medical conditions included: The patient had no known drug allergies. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204B21A expiry: UNKNOWN) dose was not reported, administered on 12-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-APR-2022, the patient experienced confirmed Covid-19 infection. Laboratory data included: COVID-19 virus test (NR: not provided) Positive. On 04-APR-2022, Laboratory data included: COVID-19 antigen test (NR: not provided) Positive. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed Covid-19 infection was not reported. This report was non-serious. This case, from the same reporter is linked to 20220406167. This report was associated with product quality complaint: 90000224615. Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.